Simmbion

Simmbion is a veteran-owned company specializing in the development of symbiotic synthetic cells for the treatment of chronic diseases. Simmbion is committed to revolutionizing the healthcare industry through innovative therapeutic solutions, thereby improving quality of life and reducing healthcare costs. The trypanosome symbiont designed by Simmbion can secrete specific therapeutic proteins. The company’s Simmbions™ can be implanted in patients through a single injection, continuously releasing medication for up to a year or longer. If necessary, Simmbions can also be reversed with antimicrobial agents, providing unprecedented control over disease management. As a result, the sustained release of biologics and other therapeutic drugs significantly reduces the need for traditional needle-based delivery methods, seamlessly integrates with many lifestyles, and decreases the complexity of cold chain logistics.